0001209191-22-035927.txt : 20220610
0001209191-22-035927.hdr.sgml : 20220610
20220610163914
ACCESSION NUMBER: 0001209191-22-035927
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220608
FILED AS OF DATE: 20220610
DATE AS OF CHANGE: 20220610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rakow John
CENTRAL INDEX KEY: 0001933028
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36579
FILM NUMBER: 221009486
MAIL ADDRESS:
STREET 1: C/O ADVERUM BIOTECHNOLOGIES, INC.
STREET 2: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adverum Biotechnologies, Inc.
CENTRAL INDEX KEY: 0001501756
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 205258327
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
BUSINESS PHONE: (650) 649-1004
MAIL ADDRESS:
STREET 1: 100 CARDINAL WAY
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
FORMER COMPANY:
FORMER CONFORMED NAME: Avalanche Biotechnologies, Inc.
DATE OF NAME CHANGE: 20100921
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-06-08
0
0001501756
Adverum Biotechnologies, Inc.
ADVM
0001933028
Rakow John
C/O ADVERUM BIOTECHNOLOGIES, INC.
100 CARDINAL WAY
REDWOOD CITY
CA
94063
0
1
0
0
SVP, Genl Counsel, Acting CFO
Stock Option (Right to Buy)
1.09
2022-06-08
4
A
0
250000
0.00
A
2032-06-07
Common Stock
250000
250000
D
Twenty-five percent (25%) of the total number of shares subject to the option vest and become exercisable on the first anniversary of June 3, 2022, and 1/48 of the total number of shares subject to the option vest and become exercisable each month thereafter, such that all of the shares subject to the option shall become vested and exercisable as of the fourth anniversary of June 3, 2022, subject to the Reporting Person's continued service with the Issuer on each such vesting date.
John Rakow, by /s/ Ron A. Metzger, Attorney-in-Fact
2022-06-10